June 21, 2024
The US Food and Drug Administration (FDA) has granted accelerated approval to adagrasib (Krazati, Mirati Therapeutics, Inc.) with cetuximab for certain patients with KRAS G12C–mutated colorectal […]
June 21, 2024
Christopher F. Freer, DO, the senior vice president of Emergency and Hospitalist Medicine at RWJBarnabas Health in New Jersey, explains that specific populations are at higher […]
June 21, 2024
On June 21, 2024, the Food and Drug Administration granted accelerated approval to adagrasib (Krazati; Mirati Therapeutics, Inc.) plus cetuximab for adults with KRAS G12C-mutated locally […]
June 21, 2024
SAN DIEGO, California — A review of prescription patterns reveals calcitonin gene-related peptide (CGRP) and gepant medications for migraine reveals significant gender and racial disparities that […]
June 21, 2024
The European Commission (EC) has granted marketing authorization for Altuvoct (efanesoctocog alfa, Sobi) to treat and prevent bleeds and for perioperative prophylaxis in hemophilia A for […]
June 21, 2024
Truqap (capivasertib, AstraZeneca) in combination with Faslodex (fulvestrant) has been approved by the European Commission for the treatment of adult patients with: estrogen receptor (ER)-positive, human […]
June 21, 2024
SAN DIEGO — ChatGPT, an artificial intelligence (AI) tool that can provide headache information, makes significant errors regarding migraine drug treatments but does better when it […]
June 21, 2024
CHICAGO — Prominent Chinese oncologist Tony Shu-Kam Mok, MD, who presented as first author of a phase 3 non–small cell lung cancer study at ASCO 2024, […]
June 21, 2024
Date: July 22, 2024 Time: 9:00 AM – 2:00 PM ET Background Efficient and effective reviews of marketing applications are an important part of FDA’s mission […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626
Next page